Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Raleigh Reporter.
Press releases published on May 16, 2025
'Journey Through Time' is an enlightening exploration of RCIA by Laurence F. Aucella
EIN Presswire
·
May 16, 2025
Dive into a groundbreaking study blending history, theology, and hard data to uncover what drives and sustains adult converts in the RCIA process. GREENVILLE, NC, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- Kravitz and Sons LLC is honored to be …
“Life of Abuse to Success: A Child’s Story” is a poignant memoir of resilience by Walter Paul Lawrence
EIN Presswire
·
May 16, 2025
A heart-rending yet hopeful journey from childhood trauma to triumph, offering guidance for families, teens, and every soul seeking healing. GREENVILLE, NC, UNITED STATES, May 16, 2025 /EINPresswire.com/ -- Kravitz and Sons LLC is delighted to be the …
Coca-Cola Consolidated’s 10-for-1 Stock Split Finalized; Shares to Trade on Split-Adjusted Basis May 27, 2025
GlobeNewswire
·
May 16, 2025
CHARLOTTE, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- Coca‑Cola Consolidated, Inc. (NASDAQ: COKE) today announced that its 10-for-1 split of the Company’s Common Stock and Class B Common Stock has been approved by its stockholders, and shares of the Company’s …
insightsoftware Launches Spreadsheet Server Integration with Infor M3 Cloud, Accelerating Self-Service Reporting in Excel
GlobeNewswire
·
May 16, 2025
RALEIGH, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- insightsoftware, the most comprehensive provider of solutions for the Office of the CFO, today announced Spreadsheet Server from insightsoftware now integrates with the Infor M3 Cloud ERP platform. This …
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)
GlobeNewswire
·
May 16, 2025
RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing …